Data protection and privacy at EMA
Submitted by Anonymous (not verified) on 28 May 2026 - 15:30
Data protection and privacy at EMA
Champix
Submitted by Anonymous (not verified) on 28 May 2026 - 15:00
Champix
SME Regulation and reports
Submitted by Anonymous (not verified) on 28 May 2026 - 14:55
SME Regulation and reports
20 years supporting small and medium enterprises (SMEs) at EMA report
Submitted by Anonymous (not verified) on 28 May 2026 - 14:45
20 years supporting small and medium enterprises (SMEs) at EMA report
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 61, Status: Authorised
Submitted by Anonymous (not verified) on 28 May 2026 - 14:36
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 61, Status: Authorised
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 3
Submitted by Anonymous (not verified) on 28 May 2026 - 14:30
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 3
Timetable: Marketing authorisation renewal application - ATMP
Submitted by Anonymous (not verified) on 28 May 2026 - 14:25
Timetable: Marketing authorisation renewal application - ATMP
Timetable: Marketing authorisation renewal application
Submitted by Anonymous (not verified) on 28 May 2026 - 14:20
Timetable: Marketing authorisation renewal application
Human medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 28 May 2026 - 12:46
Human medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: Authorised
PSUSA/00002478/202508
Submitted by Anonymous (not verified) on 28 May 2026 - 12:18
PSUSA/00002478/202508